Healiva

Healiva, founded in 2020 by Bioseutica BV and Dr. Priyanka Dutta-Passecker, is a patient-centric biotechnology company providing life-enhancing precision medicines for patients with chronic and acute wounds. Healiva creates tailored wound solutions through a multi-pronged approach that combines enzyme technology, medical devices, and cell therapy. Cell therapy describes the process of introducing living cells into the body to produce therapeutic effects; the cells can be sourced from cell banks (allogeneic cell therapy) or patient-derived cells transformed in the lab into the desired cell type or tissue (autologous cell therapy). Through the acquisition, development, and commercialization of these assets, Healiva® has entered the multi-billion-dollar wound care market.